Teplizumab (CD3) Antibody, Monoclonal
| Code | Size | Price |
|---|
| PSI-11-015-0.1mg | 0.1mg | £657.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Clonality: Recombinant Antibody
Regulatory Status: RUO
Shipping:
blue ice
Storage:
Store at -80˚C
Documents
Further Information
Additional Names:
MGA-031/MGA031;PRV-031
Background:
This is anti-CD3 monoclonal antibody used to prevent or delay the development of clinical type 1 diabetes (T1D) in high-risk groups. High-risk groups refer to the presence of 2 or more T1D-related autoantibodies in the body.
Buffer:
PBS buffer pH7.5
Concentration:
batch dependent
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Purification:
>95%
Research Area:
Drug Analogues
Source:
CHO cells
User NOte:
Optimal dilutions for each application to be determined by the researcher.